- Home
- MANU vs HCM Comparison
MANU vs HCM Comparison
Compare MANU & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANU
- HCM
- Stock Information
- Founded
- MANU 1878
- HCM 2000
- Country
- MANU United Kingdom
- HCM Hong Kong
- Employees
- MANU N/A
- HCM N/A
- Industry
- MANU Services-Misc. Amusement & Recreation
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- MANU Consumer Discretionary
- HCM Health Care
- Exchange
- MANU Nasdaq
- HCM Nasdaq
- Market Cap
- MANU 2.2B
- HCM 2.5B
- IPO Year
- MANU 2012
- HCM N/A
- Fundamental
- Price
- MANU $13.90
- HCM $13.76
- Analyst Decision
- MANU Buy
- HCM Hold
- Analyst Count
- MANU 2
- HCM 1
- Target Price
- MANU $20.75
- HCM $19.00
- AVG Volume (30 Days)
- MANU 292.3K
- HCM 128.4K
- Earning Date
- MANU 02-19-2025
- HCM 03-19-2025
- Dividend Yield
- MANU N/A
- HCM N/A
- EPS Growth
- MANU N/A
- HCM N/A
- EPS
- MANU N/A
- HCM 0.04
- Revenue
- MANU $777,029,683.00
- HCM $630,201,000.00
- Revenue This Year
- MANU $2.44
- HCM $28.98
- Revenue Next Year
- MANU $3.82
- HCM $20.41
- P/E Ratio
- MANU N/A
- HCM $63.68
- Revenue Growth
- MANU N/A
- HCM N/A
- 52 Week Low
- MANU $12.05
- HCM $11.51
- 52 Week High
- MANU $18.42
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- MANU 54.26
- HCM 46.20
- Support Level
- MANU $12.05
- HCM $13.50
- Resistance Level
- MANU $14.12
- HCM $15.11
- Average True Range (ATR)
- MANU 0.48
- HCM 0.66
- MACD
- MANU 0.17
- HCM -0.00
- Stochastic Oscillator
- MANU 89.37
- HCM 45.69
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.